Brief: Societal CDMO Selected By Spinnaker Biosciences To Execute CDMO Services In Support Of Co's Clinical Development Of A Novel Therapeutic Candidate
10/07/2023 13:10
July 10 (Reuters) - Societal CDMO Inc SCTL.O :
* SOCIETAL CDMO INC- SELECTED BY SPINNAKER BIOSCIENCES TO
EXECUTE
CDMO SERVICES IN SUPPORT OF CO'S CLINICAL DEVELOPMENT OF A NOVEL
THERAPEUTIC CANDIDATE
Source text for Eikon: ID:nGNXbNXbXf
Further company coverage: SCTL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview